Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies

INTRODUCTION: Delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) demonstrated clinical and neuroradiologic efficacy and safety in the Phase 3 DEFINE and CONFIRM trials, and in the extension study (ENDORSE), in patients with relapsing–remitting multiple sclerosis (RRMS). This...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neurol Ther
Main Authors: Gold, Ralf, Giovannoni, Gavin, Phillips, J. Theodore, Fox, Robert J., Zhang, Annie, Marantz, Jing L.
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2016
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4919132/
https://ncbi.nlm.nih.gov/pubmed/26932146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-016-0042-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki